Medicament comprising NK4 gene or recombinant NK4 protein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Sep 27, 2002
filing date -
Feb 25, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
(Problems) The present invention provides a therapeutic agent which is effective for primary tumor of cancer and, more particularly, it provides an NK4 gene therapeutic agent and a recombinant NK4 protein preparation which is effective for the prevention and therapy of cancer. The present invention also provides a therapeutic agent which is effective for metastasis of cancer and, more particularly, it provides an NK4 gene therapeutic agent and a recombinant NK4 protein preparation which is effective for the prevention and therapy of metastasis of cancer. The present invention further provides a therapeutic agent which is effective for diseases caused by neovascularization including cancer and, more particularly, it provides an NK4 gene therapeutic agent and a recombinant NK4 protein preparation which is effective for diseases caused by neovascularization. (Solving Means) DNA containing a base sequence represented by SEQ ID NO: 1 or SEQ ID NO: 2 or DNA containing a DNA which hybridizes to the said DNA under a stringent condition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully